Le Lézard
Classified in: Health
Subject: SVY

Global Animal Health Market: Industry Analysis & Outlook (2018-2022)


LONDON, August 8, 2018 /PRNewswire/ -- Animals, like humans, also suffer from diseases and hence require proper care from veterinarians, farmers and pet owners.

Download the full report: https://www.reportbuyer.com/product/4148026

Improving the health of companion animals and livestock and treating them is the foremost objective of animal health industry. The animal health industry can be broadly classified into two parts - production and companion segments. Every animal has distinct need of its own and thus, requires different treatments in accordance to its breed. Further, on the basis of products, animal health market is divided into three main sections; pharmaceuticals, vaccines, and medicinal feed additives.

The key factors driving the growth of animal health market include rising disposable income, urbanization, rising demand for animal protein, faster regulatory approvals, increasing pet expenditure in the U.S., and favorable demographic supporting pet market. Some of the noteworthy trends and developments of this industry include consolidation of the market, increasing companion ownership, and rising incidences of zoonotic diseases. However, the expansion of animal health market is hindered by highly competitive landscape for new entrants and high cost of product development.

The report "Global Animal Health Market: Industry Analysis & Outlook (2018-2022)" by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering North America, Europe, Asia-Pacific regions along with the global market. The report profiles the key players of the market including Bayer AG, Merck & Co., Inc., Eli Lilly and Company and Zoetis Inc.

Download the full report: https://www.reportbuyer.com/product/4148026

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 06:30
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior...

at 06:28
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Parenteral Packaging Market ? By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules,...

at 06:15
Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement ≥ 3 Points) including:9.29 Points for Patients at the Two-Year Milestone8.08 Points...

at 06:10
Thermo Fisher Scientific Inc. , the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: